Vitrolife evaluates measures to temporarily reduce staff costs
Vitrolife has previously announced that the company estimates that there will be a significant negative effect on the second quarter due to the reduced demand associated with the Coronavirus outbreak. The company has evaluated the situation and, if appropriate, will use the support packages in the countries concerned to temporarily reduce staff costs.Vitrolife estimates that the Coronavirus outbreak will have a significant negative impact on the demand for IVF treatments during the second quarter. The company has evaluated the situation and, if appropriate, will use the support packages in